Table 1. Baseline characteristics of patients enrolled in study of Plasmodium falciparum ex vivo RSA survival rates, Uganda, 2014–2016*.
| Characteristics | Enrolled | RSA results obtained |
|---|---|---|
| No. patients | 249 | 194 |
| 2014 Oct | 16 | 15 |
| 2015 May | 74 | 43 |
| 2015 Oct | 63 | 51 |
| 2016 June |
96 |
85 |
| Sex, no. patients | ||
| M | 126 | 92 |
| F |
123 |
102 |
| Age, y | ||
| Median (IQR) |
3.0 (2.0–4.5) |
2.9 (2.0–4.4) |
| Fever >37.5°C | ||
| No. (%) patients | 207 (83) | 177 (92) |
| Median (IQR) body
temperature, °C |
39 (38.0–39.4) |
39 (38.3–39.5) |
| Signs and symptoms, % patients | ||
| Cough | 22 | 29 |
| Vomiting | 21 | 25 |
| Abdominal pain | 11 | 21 |
| Headache | 10 | 19 |
| Diarrhea | 7 | 10 |
| Convulsion |
7 |
8 |
| Day 0 parasitemia, median (IQR), % | 1.71 (0.17–4.13) | 1.95 (0.85–4) |
*IQR, interquartile range; RSA, ring-stage survival assay.